We’re excited to share another milestone in the search for better drug treatments for ALS. Amylyx announced today that...

We’re excited to share another milestone in the search for better drug treatments for ALS. Amylyx announced today that...
In 2020, the ALS Association, in partnership with Massachusetts General Hospital, launched an innovative approach to...
Muscle and Nerve has published the results of the open label extension study of AMX0035, a promising new drug therapy...
The New England Journal of Medicine (NEJM) has published the results of a phase 2 trial (known as CENTAUR) of the...
The ALS Association and I AM ALS announced today that the organizations have awarded a combined grant of $500,000 to...
The ALS Association is excited to announce $2.5 million in grants to help develop promising new treatments for people...
This week a $3 million commitment was made by The ALS Association to the first platform trial for ALS. The platform...
Dr. Stanley Appel, neurologist and co-director of the Houston Methodist Hospital Neurology Institute, has been leading...
Our "closer to a cure" segment will highlight research news and important milestones made by researchers as they work...
Our "closer to a cure" segment will highlight research news and important milestones made by researchers as they work...
For decades, researchers have been searching for correlations that may give insight into what causes ALS. While the...
Today marks a monumental day for ALS research as the first in-human clinical trials of AT-1501 have begun. AT-1501 is...